Title

Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2012

Issue

No 1

Authors

Hiszczyńska-Sawicka, E. ; Li, H. ; Xu, J. ; Akhtar, M. ; Holec-Gąsior, L. ; Kur, J. ; Bickerstaffe, R. ; Stankiewicz, M.

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2012

Identifier

DOI: 10.2478/v10181-011-0107-7 ; ISSN 1505-1773

Source

Polish Journal of Veterinary Sciences; 2012; No 1

References

Beghetto E. (2005), A combination of antigenic regions of <i>Toxoplasma gondii</i> microneme proteins induces protective immunity against oral infection with parasite cysts, J Infect Dis, 191, 637, doi.org/10.1086/427660 ; Beláková J. (2007), DNA vaccines: are they still just a powerful tool for the future?, Arch Immunol Ther Exp (Warsz), 55, 387, doi.org/10.1007/s00005-007-0044-4 ; Buxton D. (2007), <i>Toxoplasma gondii</i> and ovine toxoplasmosis: new aspects of an old story, Vet Parasitol, 149, 25, doi.org/10.1016/j.vetpar.2007.07.003 ; Cerede O. (2002), The <i>Toxoplasma gondii</i> protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin, EMBO J, 21, 2526, doi.org/10.1093/emboj/21.11.2526 ; Chardès T. (1990), Antibody responses to <i>Toxoplasma gondii</i> in sera, intestinal secretions and milk from orally infected mice and characterization of target antigens, Infect Immun, 58, 1240. ; Dautu G. (2007), <i>Toxoplasma gondii</i>: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential, Exp Parasitol, 116, 273, doi.org/10.1016/j.exppara.2007.01.017 ; Gazzinelli R. (1996), Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to <i>Toxoplasma gondii</i>, Curr Top Microbiol Immunol, 219, 127. ; Hiszczyńska-Sawicka E. (2003), High yield expression and single-step purification of <i>Toxoplasma gondii</i> SAG1, GRA1 and GRA7 antigens in <i>Escherichia coli</i>, Prot Expr Purif, 27, 150, doi.org/10.1016/S1046-5928(02)00593-4 ; Hiszczyńska-Sawicka E. (2005), Efficient production of the <i>Toxoplasma gondii</i> GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis, Acta Parasitol, 50, 249. ; Hiszczyńska-Sawicka E. (2010a), Comparison of immune response in sheep immunized with DNA vaccine encoding <i>Toxoplasma gondii</i> GRA7 antigen in different adjuvant formulations, Exp Parasitol, 124, 365, doi.org/10.1016/j.exppara.2009.11.015 ; Hiszczyńska-Sawicka E. (2010b), The immune responses of sheep after DNA immunization with <i>Toxoplasma gondii</i> MAG1 antigen - with and without co-expression of ovine interleukin 6, Vet Immunol Immunopathol, 136, 324, doi.org/10.1016/j.vetimm.2010.03.018 ; Holec-Gąsior L. (2009), GRA2 and ROP1 recombinant antigens as potential markers for detection of <i>Toxoplasma gondii</i> - specific immunoglobulin G in humans with acute toxoplasmosis, Clin Vaccine Immunol, 16, 510, doi.org/10.1128/CVI.00341-08 ; Ismael A. (2003), The MIC3 gene of <i>Toxoplasma gondii</i> is a novel potent vaccine candidate against toxoplasmosis, Infect Immun, 71, 6222, doi.org/10.1128/IAI.71.11.6222-6228.2003 ; Ismael A. (2006), Mic1-3 knockout of <i>Toxoplasma gondii</i> is a successful vaccine against chronic and congenital toxoplasmosis in mice, J Infect Dis, 194, 1176, doi.org/10.1086/507706 ; Johnson L. (2002), Deficient humoral responses underlie susceptibility to <i>Toxoplasma gondii</i> in CD-4 deficient mice, Infect Immun, 70, 185, doi.org/10.1128/IAI.70.1.185-191.2002 ; Kang H. (2000), Decreased resistance of B cell-deficient mice to infection with <i>Toxoplasma gondii</i> despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase, J Immunol, 164, 2629, doi.org/10.4049/jimmunol.164.5.2629 ; Kur J. (2009), Current status of toxoplasmosis vaccine development, Expert Rev Vaccines, 8, 791, doi.org/10.1586/erv.09.27 ; McLeod R. (1986), Secretory IgA specific for <i>Toxoplasma gondii</i>, J Immunol, 136, 2640. ; Mévélec M. (2010), Mic1-3 Knockout <i>Toxoplasma gondii</i> is a good candidate for a vaccine against <i>T. gondii</i>-induced abortion in sheep, Vet Res, 41, 49, doi.org/10.1051/vetres/2010021 ; Payne R. (2009), The Guide to GenStat® Release 12, Part 2: Statistics. ; Pietkiewicz H. (2004), Usefulness of <i>Toxoplasma gondii</i>-recombinant antigens in serodiagnosis of human toxoplasmosis, J Clin Microbiol, 42, 1779, doi.org/10.1128/JCM.42.4.1779-1781.2004 ; Pontarollo R. (2002), Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs, Vet Immunol Immunopathol, 84, 43, doi.org/10.1016/S0165-2427(01)00379-8 ; Qu D. (2009), Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated <i>Salmonella typhimurium</i> against <i>Toxoplasma gondii</i> infection in mice, Vet Parasitol, 166, 220, doi.org/10.1016/j.vetpar.2009.08.016 ; Soldati D. (2001), Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite <i>Toxoplasma gondii</i>, Int J Parasitol, 31, 1293, doi.org/10.1016/S0020-7519(01)00257-0 ; Suzuki Y. (1988), Interferon-gamma: the major mediator of resistance against <i>Toxoplasma gondii</i>, Science, 240, 516, doi.org/10.1126/science.3128869 ; Tomley F. (2001), Mix and match modules: structure and function of microneme proteins in apicomplexan parasites, Trends Parasitol, 17, 81, doi.org/10.1016/S1471-4922(00)01761-X ; Wood P. (2001), BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis, Tuberculosis (Edinb), 81, 147, doi.org/10.1054/tube.2000.0272 ; Xiang W. (2009), The location of invasion-related protein MIC3 of <i>Toxoplasma gondii</i> and protective effect of its DNA vaccine in mice, Vet Parasitol, 166, 1, doi.org/10.1016/j.vetpar.2009.08.014